Skip to main content

Table 1 Baseline characteristics of patients with lacrimal gland carcinoma

From: Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy

Total (n = 18)Patient numberPercentage (%)
Median age (years)54 (20–85) 
Sex
 Male844.4
 Female1055.6
T stage
 115.6
 2950.0
 3316.7
 4527.7
Types of surgery
 Excision1583.3
 Needle biopsy316.7
RT treatment
 Adjuvant RT alone1372.2
 Adjuvant CCRT211.1
 Definitive RT211.1
 Definitive CCRT15.6
RT type
 3DCRT211.1
 IMRT1477.8
 Proton211.1
RT dose
 < 6600 cGy950.0
 ≥ 6600 cGy950.0
Cell type
 Adenoid cystic carcinoma950.0
 Carcinoma ex pleomorphic adenoma738.9
 Poorly differentiated adenocarcinoma211.1
Margin
 positive1372.2
 negative527.8
LVSI
 Positive633.3
 Negative1266.7
PNI
 Positive844.4
 Negative1055.6
  1. RT radiotherapy, CCRT concurrent chemoradiotherapy, 3DCRT 3-dimensional conformal radiotherapy, IMRT intensity-modulated radiotherapy, cGy centigray, LVSI lymphovascular invasion, PNI perineural invasion.